BUSINESS
Wockhardt becomes first Indian co to get DCGI nod for 2 new antibiotics
Khorakiwala said the company will be launching the two drugs in next few months in India and later in emerging markets and China.
BUSINESS
Lupin's US FDA compliance woes suggest the problem runs deeper
Tarapur is Lupin’s fifth facility in the past 12 months to be hit by regulatory compliance issues.
BUSINESS
California's move to sell generic drugs under own label may adversely affect India drug companies
"Every government will like to bring down the cost of medication. Currently the US market is fed through intermediaries. So, understandably they (California) want to cut back on the intermediaries, which have a hefty margins upwards of 10-20 percent," said Dinesh Dua, Chairman of Pharmaceuticals Export Promotion Council (Pharmexcil).
BUSINESS
PPP medical colleges — NITI Aayog's plan to address shortage of doctors
NITI Aayog has said that the proposed plan is to bring private capital to setup medical colleges and privatise operations, and management of the associated district hospital is to address shortage of qualified doctors
BUSINESS
Indian pharma market sees growth of 9.6% in Q3FY20
Growth moderated due to dip in sales of anti-infectives, gastrointestinal, pain and vitamins segments and lower inventory levels, compared to previous year.
BUSINESS
Looking to snap up Integrated Vaccine Complex, Bharat Biotech is on a steady growth path
Bharat Biotech was founded in 1994 by yeast molecular biologist Krishna Ella and his wife Suchitra Ella.
BUSINESS
Edutech platform Omnicuris is reshaping the upskilling of doctors in India, here's how
Omnicuris uses video as a medium of instruction, and offers the courses for free. The platform is also interactive, allowing doctors to ask questions to experts, take part in webinars, quizzes, assignments and assessments, among other things.
BUSINESS
Biocon Biologics IPO: Syngene encore on the cards
Syngene, which was listed in August 2015, raised Rs 550 crore. The IPO was subscribed 32 times. Incidentally, True North was an investor in Syngene before it was listed.
BUSINESS
Steer Engineering reaches out-of-court settlement with GSK over Horlicks
GSK's nutrition business is largely led by the Horlicks brand.
BUSINESS
Indian hospital revenues set to make a strong comeback in FY20
After two years of subdued performance, the hospital sector is set to bounce back in FY20, posting revenue growth of 10-12 percent in the short to medium term, ICRA said.
BUSINESS
How Christiane Hamacher looks to steer Biocon Biologics towards $1 billion sales mark
The company has set an ambitious target of clocking $1 billion in sales by FY22 through its biologics division, which is at near fourfold jump in terms of sales from FY19.
BUSINESS
Novo Nordisk names Vikrant Shrotriya as new India head
Shrotriya has over 20 years of experience in the healthcare industry.
BUSINESS
How e-commerce portal Biomall is trying to disrupt the lab products space
Products from multiple brands can be procured by a lab user located in any part of the world in a single order.
BUSINESS
Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million
Marionol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.
BUSINESS
Rantidine impurity scare: Many doctors say they still have faith in the age-old drug
In September this year, the US FDA had announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine and nizatidine.
BUSINESS
Why India needs to take a serious look at sale and consumption of tobacco
Projected tobacco-associated mortality in India is estimated reach 1.5 million by 2020
BUSINESS
Five things to watch out for in pharma and healthcare in 2020
Pharma and healthcare sectors are to some extent insulated from the general economic slowdown but a recessionary economy makes people go slow on elective surgeries.
BUSINESS
Rusan Pharma sets sight on becoming an end-to-end player in opioid drugs
Rusan has set an ambitious target of clocking sales worth Rs 1,000 crore in the next five years.
BUSINESS
Why timely action is crucial for saving stroke patients
As per ICMR report 2016 - stroke is the fourth leading cause of death and the fifth leading cause of disability.
BUSINESS
Niti Aayog looks to ensure patient safety and foster innovation in proposed Medical Devices Bill
The proposed law brings all medical devices under one regulatory regime in a phased manner, and rigour and oversight will be dependent on risk-based classification of medical devices.
BUSINESS
Here's what transpired in the Indian pharma and healthcare industry in 2019
The industry, which had a bad first-half, witnessed a rebound in the second-half of the year on the back of significant growth in domestic formulation businesses and strong exports.
BUSINESS
How Pune-based Cilicant is trying to disrupt MNC-dominated pharma desiccant market
In pharmaceuticals, desiccants play an important role in keeping the drugs stable and extending their shelf life.
BUSINESS
Vildagliptin's patent expiry to make way for new SGLT2-based drugs for type-2 diabetes treatment
The market for SGLT2 inhibitors stood around Rs 996 crore, as moving annual total (MAT) on November 2019, growing little above 20 percent.
BUSINESS
HCG to divest fertility division, focuses on tightening costs,paring debt
Fertility division contributed about 6.6 percent of the HCG's consolidated revenue of Rs 978.7 crore in FY19.
